A C H A R I T A B L E A N D G I F T P L A N N I N G G U I D E F O R T H E B A R B A R A A N N K A R M A N O S C A N C E R I N S T I T U T E

brings to a family. Before her passing, she created theFarrah Fawcett Fund for Patient Assistance to help providethe basic needs of cancer patients undergoing treatment.

Unfortunately, Farrah succumbed to her disease onJune 25, 2009, at age 62.

Today, her foundation continues its mission and thefund is available at seven cancer centers in the UnitedStates, including the Barbara Ann Karmanos CancerInstitute. The fund assists patients to defray the costs ofmedication, gas, rent/mortgage expenses, householdutility costs and other basic daily needs.

“Patient assistance grants are vital to many of thepatients we serve. Facing a cancer diagnosis isemotionally and physically challenging, and the financialburden is often overwhelming,” says Katrina Studvent,chief development officer, Karmanos Cancer Institute.“With the support of the Farrah Fawcett Fund for PatientAssistance, Karmanos Cancer Institute can provide vitalfunds for patients in need.This helps alleviate some oftheir financial burdens sopatients can focus on theirtreatment and recovery.”

To support theFarrah Fawcett Fundfor Patient Assistanceat Karmanos with atribute gift, please visitkarmanos.org/fawcettfundor call 313.576.8110.

LEGACYOF HOPE.F A L L 2 0 1 9

The Barbara Ann KarmanosCancer Institute gratefullyrecognizes actress FarrahFawcett on the 10-yearanniversary of her passing.More than 85 patients havereceived patient assistanceover the past several yearsbecause of her incrediblelegacy of caring.

Actress Farrah Fawcett was born Mary Ferrah Leni Fawcetton February 2, 1947. She was the second daughter ofPauline, a homemaker, and Jim Fawcett, an oil fieldcontractor. Farrah became a star of stage, film andtelevision. The roles that put her career on the mapincluded Jill Monroe in the 1970’s series Charlie’s Angels,and as the battered wife in the 1984 movie, The BurningBed. Though she will always be remembered for her fresh-faced beauty and iconic blond hair, it was her beautifulspirit that proved to have the most impact.

In 2006, Farrah was diagnosed with anal cancer.She was declared cancer free on her 60th birthday onFebruary 2, 2007. However, three months later, a routinedoctor’s visit revealed that cancer had returned withmetastases to her liver.

In 2007, she started the Farrah Fawcett Foundationto support anal cancer research and high-risk humanpapilloma viruses (HPV) research. In addition to cervical,vaginal, vulvar, penile and oropharyngeal cancers, HPV isresponsible for 90 percent of anal cancers.

Farrah was grateful that she could afford her own treatmentbut understood the financial burden that a cancer diagnosis

A BEAUTIFUL LEGACY:FARRAH FAWCETT FUND SUPPORTS CANCER PATIENTS

phot

o cr

edit

Bruc

e M

cBro

om c

ourte

sy o

f MPT

V Im

ages

Jeff Forman, M.D., FACR, has seen different sides ofcancer: first as a practicing oncologist for 35 yearsand then as a patient with myelofibrosis, a raremalignant bone marrow cancer. Today, he isimpacting cancer care and patients through hiscommitment to increase awareness and funding forlife-saving cancer research.

In May 2016, he received a stem cell transplant from ananonymous donor. This treatment is currently the onlyoption for surviving the disease.

Now, three years after his transplant and with no signof remaining disease, Dr. Forman is seeking donations ofa different kind — funds to support cancer research thatwill save more lives.

“I’m presently unable to return to clinical work becausethe treatment made me susceptible to infection,” says Dr.Forman, who was a radiation oncologist at the KarmanosCancer Institute from 1991 to 2007. “But I want to dowhat I can to help as many cancer patients as possible.”

More than a year ago, Dr. Forman returned to Karmanosas medical director of Development. In the past, hehelped raise funds to support the opening of Karmanos’Lawrence & Idell Weisberg Cancer Treatment Centerlocated in Farmington Hills — one of 16 Karmanos’facilities throughout Michigan. He has also beeninvolved in other fundraising initiatives at Karmanosand in the community.

“I’ve long been passionate about fundraising,”Dr. Forman says. “My work connecting with potentialdonors and raising funds, as well as community outreach,will allow Karmanos to help countless patients.”

Dr. Forman has always been aware of the importanceof cancer research programs like those underway atKarmanos, a National Cancer Institute-designatedcomprehensive cancer center. His transplant experiencegave him another perspective on how research helpssave lives.

“Up to 50 percent of bone marrow and stem celltransplant patients develop complications caused by animmune system reaction called graft versus host disease[GVHD], which can be fatal,” says Dr. Forman. In fact,Dr. Forman developed a type of GVHD following histransplant that impacts his liver. “Through medication, Ican control my GVHD. This treatment is a direct result ofpast research. That’s why I’m a passionate advocate forresearch into preventing and treating GVHD.”

Earlier this year, on the occasion of what he callshis third “transplantiversary,” Dr. Forman launched afundraising program to support testing for a newGVHD treatment at Karmanos. The goal is to raise$100,000 to support this life-saving initiative. TheBrown Family Research Fund will match the first$30,000 in contributions.

“Research continues to improve the success of ourcancer treatments,” Dr. Forman says. “Although many

THE OTHER SIDEOF CANCER:DOCTOR COMMITTED TO IMPACTING CANCER PATIENTSIN A DIFFERENT ROLE – POST LIFE-SAVING TRANSPLANT

patients today can be cured of cancer, many others are not.It’s only through research that we’ll find better treatments tocure cancer and keep patients alive with good quality of life.”

Dr. Forman and his wife, Miriam, recently celebrated their40th wedding anniversary. The couple have three adultchildren, and four of their five grandchildren were born afterDr. Forman had his stem cell transplant.

“I had a pretty rough time following my transplant,” saysDr. Forman, who developed pneumonia, heart and kidneyfailure, and liver and respiratory problems while hospitalized.“I was in the intensive care unit for two weeks and was putin a medically induced coma. I started getting better about18 days after the transplant.

“Through this experience, I learned how important familyis to me. I want other patients to be able to experience thissame feeling of positivity following cancer treatment — toenjoy life with their families for as long as possible. The wayto make this happen is by improving cancer treatments. Andthe only way to do that is through research.”

To learn more about the GVHD Research Initiativeat Karmanos, please call 313.576.8115 or visitkarmanos.org/JeffForman.

In celebration of his third “transplantiversary” after battlingmyelofibrosis, Jeff Forman, M.D., FACR, is raising funds tosupport research and testing for a new graft versus hostdisease [GVHD] treatment at Karmanos Cancer Institute.

KARMANOSCANCER INSTITUTEPLANNED GIVINGADVISORY COMMITTEECharles Nida, Honigman Miller Schwartz and Cohn,

LLP — Committee ChairDavid Aquilina, Wells Fargo Advisors, LLCLyndsey Artes, Daren Findling Law Firm, PLCRonald Bassey, Sapharan, Inc.Gary Bice, UBSAstrid Braeuer, BDO USA, LLPLawrence Brown, CPALaura Brownfield, Bodman PLCAngie Choukourian, Huntington Private BankMichael Cicchella, Cicchella and Associates, LLCMichael G. Cumming, DykemaJohn Dankovich, MKD Wealth Coaches, LLCRick Favor, Deloitte Tax, LLPJay Hack, Raymond JamesGregory C. Hamilton, Hamilton and

Associates, PLLCRebecca Herr, Northern TrustJ.R. Hesano, UBS FinancialAndrew Hopko, Barris, Sott, Denn & Driker, PLLCW. Theodore HuebnerDawn R. Jinsky, Plante Moran, PLLCMallory A. Kallabat, Clark HillRobert Kaplow, Maddin Hauser Roth & Heller, PCRobert Kass, Barris Sott Denn & Driker, PLLCBernard Kent, Schechter Investment Advisors, LLCMickey Kittredge, Citizens Bank Wealth ManagementRick Kress, Kress ConsultingJudy Fertel Layne, Dickinson Wright, PLLCHenry P. Lee, Howard & HowardMarguerite Munson Lentz, Bodman, PLCChristopher M. Mann, Dawda, Mann, Mulcahy &

Sadler, PLCMary Mansfield, Mansfield Law, PLLCLynn L. Marine-Adams, Marine Adams Law, PCTammy Moncrief, Yeo & YeoMary Nichols, Comerica Bank Wealth ManagementTodd Pado, Huntington Private BankNicholas E. Papasifakis, Clark HillMark W. Rheaume, PNC Wealth ManagementKelley H. Saros, JP Morgan Private BankLaura Ann Schreiner, Laura Ann Schreiner, PLCBrian Simmons, Baker Tilly Virchow Krause, LLPJames Studinger, JP Studinger GroupRonald J. Zadora, Monaghan, PC

4100 John R, Detroit, MI 48201

Gerold Bepler, M.D., Ph.D.President and Chief Executive OfficerKatrina StudventChief Development Officer1.800.KARMANOS 1.800.527.6266 karmanos.org

© Barbara Ann Karmanos Cancer Institute and The Stelter Company | The information in this publication is not intended as legal or tax advice. For such advice, please consult an attorney or tax advisor.Figures cited in any examples are for illustrative purposes only. References to tax rates include federal taxes only and are subject to change. State law may further impact your individual results.

Contact the Office of Planned Giving at 313.576.8115 or johnsoli@karmanos.org and we’ll help you get startedwith creating a plan that protects the important people and causes in your life.

If you own stock that’s increased in value since youpurchased it (and you’ve owned it for at least oneyear), you have a unique opportunity forphilanthropy. When you donate securities to theKarmanos Cancer Institute, you receive the sameincome tax savings (if you itemize) that you would ifyou wrote Karmanos a check, but with the addedbenefit of eliminating capital gains taxes on thetransfer, which can be as high as 20 percent.

Making a gift of securities to support transformativecancer care, research and education is as easy asinstructing your broker to transfer the shares or, if youhave the physical securities, hand-delivering or mailingthe certificates along with a stock power to Karmanosin separate envelopes.

Using assets other than cash also allows you moreflexibility when planning your gift, and there are even

more potential benefits if you plan your gift creatively.For example, if you aren’t ready to give up these assetsduring your lifetime, a gift of securities through your willor living trust allows you the flexibility to change yourmind at any time. You can continue to receive dividendsand participate in shareholder votes, and the securitiesare still yours if you need them for other expenses.

Through creative gift planning, you can secure yourown financial future and help support a world free ofcancer. We can work with your advisors to help you planfor tomorrow and receive maximum benefits today.

TAKE THE NEXT STEPWe can help clarify and document the steps to donatestock to Karmanos. Simply contact the Office ofPlanned Giving to see how this gift can be win-win.

GROWING STOCK, GROWING GENEROSITYH O W A G I F T O F S T O C K C A N B E W I N - W I N

Mission: To lead in transformative cancer care, research and education through courage, commitment and compassion.